account_balance
Investment manager · 13F filer · SEC CIK 1678378
Mass General Brigham, Inc
Reported value$456Mas of Sep 30, 2026
Positions9 4 new, 1 sold out
Top 10 weight100.0%VT alone is 66%
FiledNov 334 days after quarter end
Portfolio · as of Sep 30, 2026
Where the money is
New or addedTrimmedHeld
This fund reports 9 stocks.
VTVanguard Intl Equity Index F
65.8%New
RVMDRevolution Medicines, Inc.
15.5%
SPCXSpace Exploration Technologies Corp
7.7%New
LYNXLyntris Inc.
5.2%New
TNGXTango Therapeutics, Inc.
1.9%
MAZE1.5%KRMN1.5%MDLNBox size is the share of the fund. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 9 as a list
VT Vanguard Intl Equity Index F 65.8% New
RVMD Revolution Medicines, Inc. 15.5% HeldSPCX Space Exploration Technologies Corp 7.7% NewLYNX Lyntris Inc. 5.2% NewTNGX Tango Therapeutics, Inc. 1.9% HeldMAZE Maze Therapeutics, Inc. 1.5% Added +4%KRMN Karman Holdings Inc. 1.5% Trimmed −87%MDLN Medline Inc. 0.5% HeldIOT Samsara Inc. 0.3% NewWhat changed
Biggest moves since Jun 30, 2026
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.